dual FZD and LRP5/6 agonist (AntlerA Therapeutics)

N/A

Report date: 2025/03/19 09:03:31

Base Information

Drug Namedual FZD and LRP5/6 agonist (AntlerA Therapeutics)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionFrizzled receptors agonistsLow-density lipoprotein receptor-related protein 6 stimulantsLow-density lipoprotein receptor-related protein 5 stimulants

TargetsLow-density lipoprotein receptor-related protein 5Frizzled receptorsLow-density lipoprotein receptor-related protein 6

Therapy Area/IndicationsIrritable Bowel Syndrome

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAntlerA Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesAntlerA Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsIrritable Bowel Syndrome

Inactive IndicationsN/A

Other Information

ATC CodeN/A